317 related articles for article (PubMed ID: 28560723)
1. Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study.
Rekhi G; Rapisarda A; Lee J
Early Interv Psychiatry; 2019 Feb; 13(1):73-78. PubMed ID: 28560723
[TBL] [Abstract][Full Text] [Related]
2. Sources of clinical distress in young people at ultra high risk of psychosis.
Rapado-Castro M; McGorry PD; Yung A; Calvo A; Nelson B
Schizophr Res; 2015 Jun; 165(1):15-21. PubMed ID: 25890793
[TBL] [Abstract][Full Text] [Related]
3. Distress in relation to attenuated psychotic symptoms in the ultra-high-risk population is not associated with increased risk of psychotic disorder.
Power L; Polari AR; Yung AR; McGorry PD; Nelson B
Early Interv Psychiatry; 2016 Jun; 10(3):258-62. PubMed ID: 25772939
[TBL] [Abstract][Full Text] [Related]
4. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
[TBL] [Abstract][Full Text] [Related]
5. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
[TBL] [Abstract][Full Text] [Related]
6. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
[TBL] [Abstract][Full Text] [Related]
7. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
[TBL] [Abstract][Full Text] [Related]
9. Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up.
Cropley VL; Lin A; Nelson B; Reniers RLEP; Yung AR; Bartholomeusz CF; Klauser P; Velakoulis D; McGorry P; Wood SJ; Pantelis C
Schizophr Res; 2016 Jun; 173(3):152-158. PubMed ID: 26032566
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis.
Fusar-Poli P; De Micheli A; Cappucciati M; Rutigliano G; Davies C; Ramella-Cravaro V; Oliver D; Bonoldi I; Rocchetti M; Gavaghan L; Patel R; McGuire P
Schizophr Bull; 2018 Feb; 44(2):264-275. PubMed ID: 28521060
[TBL] [Abstract][Full Text] [Related]
11. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
[TBL] [Abstract][Full Text] [Related]
12. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
Yung AR; Yuen HP; McGorry PD; Phillips LJ; Kelly D; Dell'Olio M; Francey SM; Cosgrave EM; Killackey E; Stanford C; Godfrey K; Buckby J
Aust N Z J Psychiatry; 2005; 39(11-12):964-71. PubMed ID: 16343296
[TBL] [Abstract][Full Text] [Related]
13. Subjective experience of social cognition in young people at Ultra-High Risk of psychosis: a 2-year longitudinal study.
Pelizza L; Poletti M; Azzali S; Garlassi S; Scazza I; Paterlini F; Chiri LR; Pupo S; Raballo A
Nord J Psychiatry; 2021 Feb; 75(2):97-108. PubMed ID: 32762506
[TBL] [Abstract][Full Text] [Related]
14. Early psychotic experiences: Interventions, problems and perspectives.
Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of attenuated psychotic symptoms in help-seeking youth.
Hazan H; Spelman T; Amminger GP; Hickie I; McGorry PD; Phillips LJ; Purcell R; Wood SJ; Yung AR; Nelson B
Schizophr Res; 2020 Jan; 215():277-283. PubMed ID: 31615738
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of a two-stage strategy using the 16-item Prodromal Questionnaire (PQ16/fPQ16) and the Comprehensive Assessment of At Risk Mental States (CAARMS) in the early detection of Ultra High Risk (UHR) patients in Lebanon: a cross-sectional pilot study.
Mourad M; Atallah EP; Raad G; Haddad R; Richa S
Encephale; 2024 Feb; 50(1):40-47. PubMed ID: 36717331
[TBL] [Abstract][Full Text] [Related]
17. The approved Italian version of the comprehensive assessment of at-risk mental states (CAARMS-ITA): Field test and psychometric features.
Pelizza L; Paterlini F; Azzali S; Garlassi S; Scazza I; Pupo S; Simmons M; Nelson B; Raballo A
Early Interv Psychiatry; 2019 Aug; 13(4):810-817. PubMed ID: 29696795
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
[TBL] [Abstract][Full Text] [Related]
19. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
[TBL] [Abstract][Full Text] [Related]
20. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?
Nelson B; Yuen K; Yung AR
Schizophr Res; 2011 Jan; 125(1):62-8. PubMed ID: 21074975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
